Galapagos NV
GLPG
#4540
Rank
HK$17.44 B
Marketcap
HK$264.69
Share price
-0.73%
Change (1 day)
47.64%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -HK$4.16 Billion

According to Galapagos NV's latest financial reports the company's current earnings are HK$0.32 Billion. In 2024 the company made an earning of -HK$45.15 Million, an increase over its 2023 earnings that were of -HK$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$4.16 Billion9095.39%
2024 -HK$45.15 Million-82.77%
2023 -HK$0.27 Billion-85.59%
2022 -HK$1.82 Billion60.71%
2021 -HK$1.14 Billion-60.08%
2020 -HK$2.84 Billion-331.44%
2019 HK$1.22 B-523.76%
2018 -HK$0.29 Billion-72.34%
2017 -HK$1.05 Billion-329.59%
2016 HK$0.45 B-144.3%
2015 -HK$1.03 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$253.10 B-6,184.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$63.57 B-1,628.56%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$12.96 B-411.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$71.09 B-1,809.31%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$180.39 B-4,437.01%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$102.26 B-2,558.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$72.83 B-1,851.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-HK$0.42 Billion-89.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$13.84 B-432.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel